Omara Dogar, Ada Keding, Rhian Gabe, Anna‐Marie Marshall et al.
BACKGROUND: Smoking cessation is important in patients with tuberculosis because it can reduce the high rates of treatment failure and mortality. We aimed to assess the effectiveness and safety of cystine as a smoking cessation aid in patients with tuberculosis in Bangladesh and Pakistan. METHODS: W...
Kamran Siddiqi, Ada Keding, Anna‐Marie Marshall, Omara Dogar et al.
Background Despite treatment, patients with tuberculosis (TB) who smoke have poorer outcomes compared with non-smokers. It is unknown, however, if quitting smoking during the 6 months of TB treatment improves TB outcomes. Methods The TB & Tobacco Trial was a double-blind, placebo-controlled rand...
Omara Dogar, Deepa Barua, Melanie Boeckmann, Helen Elsey et al.
BACKGROUND AND AIMS: Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations, behavioural support combined with pharmacotherapy is the most effective strategy in helping people to quit. However, there is no evidence for t...
Melanie Boeckmann, Sahil Khan Warsi, Maryam Noor, Omara Dogar et al.
Smoking worsens tuberculosis (TB) outcomes. Persons with TB who smoke can benefit from smoking cessation. We report findings of a multi-country qualitative process evaluation assessing barriers and facilitators to implementation of smoking cessation behaviour support in TB clinics in Bangladesh and ...
Jinshuo Li, Steve Parrott, Ada Keding, Omara Dogar et al.
OBJECTIVES: To assess the cost-effectiveness of cytisine over and above brief behavioural support (BS) for smoking cessation among patients who are newly diagnosed with pulmonary tuberculosis (TB) in low-income and middle-income countries. DESIGN: An incremental cost-utility analysis was undertaken ...
Omara Dogar, Ada Keding, Rhian Gabe, Anna‐Marie Marshall et al.